"Endgame" Issues for the Global Polio Eradication Initiative
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The polio eradication initiative, created after the World Health Assembly resolved, in 1988, to eradicate poliomyelitis globally by 2000, has made remarkable progress. From 1988 through 2000, the number of countries where polio was endemic decreased from >125 to 20, and the estimated number of polio cases decreased from 350,000 to <3500, for a percentage decrease of >99%. Wild-type 2 poliovirus has not been detected worldwide since October 1999, despite improving surveillance. The major focus of the eradication effort is to complete the task of stopping wild-type poliovirus transmission. Given the rapid progress made toward this goal, planning for the posteradication era has begun in earnest (1) to minimize the risk of reintroduction of virus into the population from laboratory stocks or long-term carriers, and (2) to prevent vaccine-derived polioviruses from circulating and causing outbreaks. This report summarizes the current thinking about these "endgame" issues, as put forth by the World Health Organization's technical advisory body for the initiative, the Technical Consultative Group on the Global Eradication of Poliomyelitis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Currently, there is no clear evidence of spread of iVDPVs from immunodeficient patients to the wider community (57, 63, 68).”
From Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993 (2003) · cites this paper as [63]
In the citing paper
“The number of viable options for the endgame strategy using the existing poliovirus vaccines now appears to be quite limited (12, 38, 63).”
From Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993 (2003) · cites this paper as [63]
In the citing paper
“Consequently, early detection of any future type 2 cVDPV outbreaks will require maintenance, and possible augmentation in some countries (54), of the present very high global standard for AFP and poliovirus surveillance (63, 72).”
From Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993 (2003) · cites this paper as [63]
In the citing paper
“Transition from OPV to IPV is likely to continue in polio-free countries, especially in developed countries in temperate zones where IPV efficacy is highest (67) and where high rates of IPV coverage can be maintained through routine immunization (63).”
From Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993 (2003) · cites this paper as [63]
In the citing paper
“The recognition that cVDPVs can cause polio outbreaks and potentially reestablish polio endemicity to polio-free areas has prompted a reassessment of global strategies for maintaining polio-free status after wild poliovirus circulation has ceased (12, 15, 38, 63, 68).”
From Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993 (2003) · cites this paper as [63]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Strebel, P. M., Sutter, R. W., Cochi, S. L., Biellik, R. J., Brink, E. W., Kew, O. M., Pallansch, M. A., Orenstein, W. A., & Hinman, A. R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.568 · Cited by 337
WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines (1997) · Journal of Infectious Diseases · doi:10.1093/infdis/175.supplement_1.s215 · Cited by 88
The Polio Eradication Effort: Should Vaccine Eradication Be Next?
Dove, A. W., & Racaniello, V. R. (1997) · Science · doi:10.1126/science.277.5327.779 · Cited by 71
Research works printed but not linked: 12
- 2001, MMWR. Morbidity and mortality weekly report, 50, 320
- 1998, Weekly epidemiological record / Health Section of the Secretariat of the League of Nations, 73, 113
- 2001, 67, 397
- 2001, MMWR. Morbidity and mortality weekly report, 50, 620
- 1962, BMJ, i, 743
- 2001, International Journal of Epidemiology, 20, 1029
- 2000, MMWR. Morbidity and mortality weekly report, 49, 156
- 2001, MMWR. Morbidity and mortality weekly report, 50, 147
- 2001, MMWR. Morbidity and mortality weekly report, 50, 874
- 2001, MMWR. Morbidity and mortality weekly report, 50, 41
- 2001, Bulletin of the World Health Organization, 78, 347
- 2001, Clinical Infectious Diseases, 33, 79
Cited by
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993
Yang, C.-F., Naguib, T., Yang, S.-J., Nasr, E., Jorba, J., Ahmed, N., Campagnoli, R., van der Avoort, H., Shimizu, H., Yoneyama, T., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8366-8377.2003 · Cited by 233
Risks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After Eradication
Tebbens, R. J. D., Pallansch, M. A., Kew, O. M., Cáceres, V. M., Jafari, H., Cochi, S. L., Sutter, R. W., Aylward, R. B., & Thompson, K. M. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00827.x · Cited by 174
Fractional Doses of Inactivated Poliovirus Vaccine in Oman
Mohammed, A. J., AlAwaidy, S., Bawikar, S., Kurup, P. J., Elamir, E., Shaban, M. M. A., Sharif, S. M., van der Avoort, H. G. A. M., Pallansch, M. A., Malankar, P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909383 · Cited by 172
Sutter, R. W., Kew, O. M., & Cochi, S. L. (2008) · Vaccines · doi:10.1016/b978-1-4160-3611-1.50030-1 · Cited by 167
Metadata
- Authors
- Technical Consultative Group to the World Health Organization on the Global Eradication of Poliomyelitis
- Corresponding author
- Technical Consultative Group to the World Health Organization on the Global Eradication of Poliomyelitis
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-01-01
- Volume
- 34
- Issue
- 1
- Pages
- 72-77
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W4255162284
- Cited by
- 61
- References
- 3
- Citations by year
- 2026: 1 · 2025: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2017: 2 · 2015: 1 · 2014: 1 · 2013: 3
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- polio eradication, poliomyelitis, wild-type poliovirus, vaccine-derived poliovirus, polio surveillance
- MeSH terms
- Humans, Poliomyelitis, World Health Organization, Poliovirus Vaccines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: "Endgame" Issues for the Global Polio Eradication Initiative. https://app.cochat.ai/papers/10.1086/338262
- The paper
- Technical Consultative Group to the World Health Organization on the Global Eradication of Poliomyelitis. (2002). "Endgame" Issues for the Global Polio Eradication Initiative. Clinical Infectious Diseases. https://doi.org/10.1086/338262
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.